Physician profile
Ali M Strocker
NPI 1154447902
$831.81
in general payments reported to CMS, 2019-2025
11 companies · $551 in 2025
The $551 reported for 2025 was more than what 79% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.55 · 2020: $16.92 · 2021: $20.80 · 2024: $194 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $745.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $227.94 | 2025 | Nucala |
| Inspire Medical Systems, INC. | $194.31 | 2024 | Inspire |
| Genzyme Corporation | $136.73 | 2025 | |
| Merck Sharp & Dohme LLC | $100.30 | 2025 | Enflonsia |
| Stryker Corporation | $60.50 | 2019-2025 | Xpress Loprofile |
| Hikma Pharmaceuticals USA | $22.86 | 2025 | Ryaltris |
| Acclarent, INC | $21.81 | 2019 | |
| Cochlear Americas | $20.80 | 2021 | |
| Smith+Nephew, INC. | $16.92 | 2020 | |
| Medtronic, INC. | $15.29 | 2025 | Pteye Parathyroid Detection System |
| Neurent Medical Limited | $14.35 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Strocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.